XRCC1 and Patent ductus arteriosus: β-lap treatment caused S as well as G2/M arrest in PDA cells, consistent with previous reports indicating that β-lap induced a cell cycle arrest in S phase/ G2/M-phase in diverse cancer cell lines [20–22], and XRCC1 knockdown had no detectable effect on cycle.